A low stool-test result needs to be interpreted alongside symptoms and medical history. Contextual consultation photograph, not a diagnostic image.
A low faecal elastase result can suggest that the pancreas is not supplying enough digestive enzymes, but it is not a diagnosis on its own. The consistency of the stool sample, the degree of the reduction, symptoms and medical history all affect its meaning. A watery sample can dilute elastase and produce a misleadingly low concentration.
The useful next step is a clinical interpretation, not an assumption that the result proves a particular pancreatic disease. Persistent diarrhoea, oily stools or unexplained weight loss deserve assessment, while sudden severe abdominal pain, bleeding or jaundice need a more urgent route. A consultation can help bring the result and symptoms together and identify whether repeat testing, nutritional assessment or specialist investigation is appropriate.
What does faecal elastase measure?
Elastase is an enzyme made by the pancreas. The faecal elastase test measures its concentration in a stool sample as a non-invasive marker of the pancreas's enzyme-producing function. Reports may abbreviate it to FE-1 or FEL-1. It is different from blood tests used to assess an episode of acute pancreatic inflammation.
The test is commonly used when symptoms raise concern about pancreatic exocrine insufficiency, often shortened to PEI. This means that digestive enzyme activity is inadequate for normal digestion. The result does not show the pancreas's shape, identify the cause of a problem or measure insulin production. Those are separate clinical questions.
What counts as a low result?
Many UK laboratories regard a result above 200 micrograms per gram of stool as within the reference range. Values between 100 and 200 may suggest mild to moderate insufficiency, while a result below 100 is more concerning for severe insufficiency. The reporting laboratory's own ranges, units and interpretative comments should always be used.
These bands describe the strength of a finding, not a complete diagnosis. A borderline result from a watery sample has a different context from a repeatedly very low result in someone with established pancreatic disease and weight loss. The number should be considered with symptoms, nutritional status and any previous imaging or tests.
Why does a watery sample matter?
The measurement is a concentration. Extra water in diarrhoea can make the elastase concentration appear lower even when enzyme production is not reduced to the degree suggested. NHS laboratory guidance recommends a formed sample and cautions that very watery samples can lead to falsely low results. A repeat sample may therefore be appropriate.
A laboratory study published in 2023 found that 29 of 41 low results from watery samples were within the normal range when compared with a formed sample from the same person. This was a single-centre observational study, not a guarantee that a particular result is false. Its practical message is to check sample quality before attaching a lifelong diagnosis to one number.
Which symptoms can accompany pancreatic enzyme insufficiency?
Symptoms may include loose stools, bloating, abdominal discomfort and stools that are oily, difficult to flush or unusually bulky. Weight loss or nutritional deficiencies can develop when food is not digested and absorbed adequately. However, the symptoms are not specific, and the absence of obvious oily stools does not reliably exclude a problem.
Coeliac disease, inflammatory bowel conditions, bile acid diarrhoea, medicines and other causes of persistent diarrhoea can produce overlapping symptoms. A normal body mass index does not rule out nutritional problems. Changes in weight over time, food intake and the overall clinical history can be more informative than appearance or one measurement alone.
What can cause genuine pancreatic enzyme insufficiency?
Recognised causes include chronic pancreatitis, severe episodes of acute pancreatitis, pancreatic surgery and other pancreatic disease. It can also occur in association with conditions outside the pancreas, including some bowel disorders. The likely cause depends on the history and other findings; a stool result cannot distinguish between them.
A low result is not itself a cancer diagnosis. Nevertheless, confirmed unexplained insufficiency needs a reasoned investigation of the underlying cause. UK practical guidelines recommend appropriate pancreatic imaging in that assessment. Reassurance and investigation are not opposites: the aim is to avoid an unsupported label while not overlooking a condition that needs treatment.
When might the test be repeated?
A clinician may consider repeating the test when the original sample was watery, the result is borderline or the clinical picture does not fit. A repeat may also be useful when no cause has been identified after further assessment. The decision should account for the severity of symptoms and any risk of malnutrition.
Repeat testing should not become a reason to delay necessary care in someone with significant weight loss or established high-risk pancreatic disease. In some situations treatment and investigation proceed together. A clear plan should explain what the repeat is intended to establish and which symptoms need attention while it is pending.
Do pancreatic enzyme capsules affect the test?
Faecal elastase testing measures human elastase. UK guidance and NHS laboratory information state that pancreatic enzyme replacement therapy does not interfere with this measurement. This is useful when repeat testing is needed after treatment has started. It does not mean that prescribed treatment should be stopped or changed without advice.
Always follow the instructions from the requesting clinician and the laboratory handling the sample. Other stool investigations may have different preparation requirements. The original report, current prescriptions and any collection guidance help avoid confusion between different tests or between a diagnostic sample and routine treatment monitoring.
What happens during a clinical review?
A review considers the exact result, sample consistency, symptom duration, bowel pattern and weight change. Previous pancreatitis, surgery, diabetes, bowel disease and family history may be relevant. The clinician also reviews medicines, supplements and food intake, and considers whether an in-person examination is needed.
For clients arranging an online consultation, having the full report rather than a cropped number makes interpretation more useful. Remote review can help organise the next step, but it cannot examine abdominal tenderness, assess dehydration fully or exclude a serious abdominal condition. Urgent symptoms should be assessed through an appropriate urgent service rather than waiting for a routine remote appointment.
Which further tests might be considered?
Further investigations are chosen for the clinical question. They may include blood tests for nutritional status and other causes of symptoms, additional stool tests or pancreatic imaging. A gastroenterology opinion may be appropriate. Not every person needs every test, and an isolated borderline result should not automatically trigger an indiscriminate panel.
Imaging can help find structural pancreatic disease or another explanation, but it is not a direct replacement for assessing digestive function. Conversely, a faecal elastase result does not replace imaging when there is a reason to investigate the pancreas. Clinical history, laboratory tests and imaging each answer different parts of the assessment.
How is confirmed insufficiency treated?
Pancreatic enzyme replacement therapy, or PERT, is a main treatment for confirmed insufficiency. It supplies enzymes to help digest food. The prescription, dose and review plan should reflect meals, symptoms, weight and nutritional needs. Dietetic support can be important, especially when weight is falling or eating has become difficult.
Enzymes are generally taken with food and spread through the meal, according to the prescribed instructions. People should receive practical advice about timing and administration rather than simply a prescription. Existing products are usually derived from porcine sources, which may matter for dietary or religious reasons and should be discussed openly with the treating team.
Should I cut out fat?
A low-fat diet is not routinely recommended for pancreatic enzyme insufficiency. Unnecessary restriction can make it harder to maintain weight and adequate nutrition. Food intake and enzyme treatment need to be considered together. Advice should be tailored when there are other conditions, food intolerances or specific nutritional requirements.
Do not respond to a low stool result by removing several food groups or buying high-dose supplements without assessment. Persistent symptoms can make eating feel uncertain, but a restrictive diet may create additional problems. A clinician or dietitian can help establish whether symptoms reflect digestion, another bowel condition or a combination of factors.
What if symptoms continue despite enzymes?
Ongoing symptoms do not automatically mean that more enzymes are the only answer. The treatment team may review timing, dose, whether enzymes accompany all relevant food, storage and the original diagnosis. Other causes of diarrhoea, including coeliac disease, bile acid diarrhoea or small bowel bacterial overgrowth, may need consideration.
Follow-up should assess weight, bowel symptoms, food intake and nutritional markers where appropriate. The goal is effective digestion and a sustainable treatment plan, not simply changing a test number. The faecal elastase test is not a direct measure of how well replacement capsules are working during each meal.
When is urgent care needed?
Call 999 or go to A&E for sudden severe abdominal pain, vomiting blood or material like coffee grounds, a large amount of rectal bleeding or black sticky stools. Do not drive yourself. These symptoms require urgent assessment regardless of the elastase result and should not be managed through a routine test-review appointment.
Yellowing of the skin or whites of the eyes needs an urgent GP appointment or NHS 111 advice, especially if urine is dark or stools are pale. Worsening abdominal pain, persistent vomiting or diarrhoea, blood in the stool and unexplained weight loss also deserve prompt clinical assessment. A low elastase result should not distract from the urgency of the symptoms themselves.
Discuss a non-urgent faecal elastase result.
Frequently asked questions
Does a low faecal elastase result mean pancreatic cancer?
No. The test does not diagnose cancer and several pancreatic and non-pancreatic conditions can be associated with a low result. Watery stool can also cause a misleading reduction. Confirmed unexplained insufficiency does need assessment of its cause, so the right response is a considered investigation rather than either assuming the worst or ignoring it.
Is a result between 100 and 200 always abnormal?
Many laboratories flag this range, but interpretation depends on the report, sample quality and clinical context. A clinician may recommend a repeat on a formed sample or further assessment. The result alone does not establish the cause, severity of nutritional effects or need for long-term treatment.
Can a normal result rule out every pancreatic problem?
No. The test is less sensitive for mild enzyme insufficiency and does not assess all pancreatic conditions. Persistent concerning symptoms or a strong medical history can justify further review despite a result within range. It is a useful investigation, not a universal pancreatic health check.
Should I start enzyme capsules myself?
Do not use a stool number as a reason to self-prescribe treatment. A clinician should assess the result and symptoms, consider the cause and agree the right preparation and follow-up. In some high-risk situations treatment is started promptly, but that is a clinical decision rather than a general rule for every low result.
Is faecal elastase the same as calprotectin?
No. Elastase is used to assess pancreatic enzyme function. Calprotectin is a different stool marker used in the assessment of bowel inflammation. A reassuring result on one test does not automatically answer the question asked by the other, and neither should be interpreted without the relevant symptoms and history.
What information should I bring to a consultation?
The full laboratory report, whether the sample was formed or watery, the symptom timeline, weight changes and current medicines are useful. Previous scans, pancreatic or bowel diagnoses and any enzyme prescription also help. A focused review can then explain what is established, what remains uncertain and which next step addresses that uncertainty.
Sources
Leeds Teaching Hospitals NHS Trust, Faecal elastase
University Hospitals Birmingham NHS, Faecal elastase
UK practical guidelines for pancreatic exocrine insufficiency, 2021